Capricor Therapeutics, Inc.CAPR
ASignal's systematic analysis rates CAPR as Neutral.
Reflects the latest available analysis · analyzed Sep 4, 2026
The case on CAPR
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive price momentum above 20-day moving average
- MACD histogram expanding and MACD above signal line indicating strengthening momentum
- High current and quick ratios suggesting strong liquidity position
- Cash reserves significantly exceed total debt
- Negative return on equity and return on assets
- Negative operating and free cash flow trends
- No profitability margins (gross, operating, net)
- Forward P/E and EV/EBITDA suggest negative earnings outlook
- No Reddit retail sentiment data available
See the full verdict on CAPR
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CAPR
Most investors never get a second opinion, let alone several. ASignal runs CAPR past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.